Essayer OR - Gratuit
Coliform bacteria and E. coli in pharma water systems: A hidden threat to product integrity
Express Pharma
|May 2025
Water quality is critical in pharma manufacturing, and contamination by coliforms or E. coli can threaten product safety and compliance. Dr Girish B Mahajan, Sr VP - Microbiology, HiMedia Laboratories examines the risks, regulatory focus, and new technologies for real-time microbial monitoring in this article
-
The COVID-19 pandemic brought microbiology to the public eye, making terms like RT-PCR, antigen, and PPE kit part of everyday discussions. In the pharmaceutical world, another set of terms-coliforms and E. coli-carry immense importance, especially where water quality is concerned. Water is a critical utility in pharma manufacturing processes and is used in various stages including formulation, cleaning, and even as raw material in some products. Any microbial contamination in the water supply chain can have cascading effects on product integrity, batch sterility, and ultimately patient safety.
Pharma-grade water systems like Purified Water (PW), Water for Injection (WFI), and Clean-in-Place (CIP) are designed with rigorous microbial quality parameters. However, coliform bacteria-especially E. coli-serve as early indicators of water system failures and contamination by fecal matter or biofilm development. A recent E. coli outbreak in 2024 due to contaminated food illustrated how lapses in microbial control can spiral into public health emergencies. For the pharma industry, the implications are even more severe, with potential regulatory actions, product recalls, and brand damage.
Understanding coliforms and their relevance in pharma
Coliform bacteria, comprising genera such as Escherichia, Citrobacter, Enterobacter, and Klebsiella, are Gram-negative, rod-shaped microorganisms commonly found in the environment, including soil, surface water, and the gastrointestinal tracts of warm-blooded animals. Though most are not pathogenic, their presence in pharma water systems-especially Escherichia coli, which indicates faecal origin-raises serious red flags regarding the integrity of production processes.
Cette histoire est tirée de l'édition May 2025 de Express Pharma.
Abonnez-vous à Magzter GOLD pour accéder à des milliers d'histoires premium sélectionnées et à plus de 9 000 magazines et journaux.
Déjà abonné ? Se connecter
PLUS D'HISTOIRES DE Express Pharma
Express Pharma
Standardisation vs customisation in single-use systems for bioprocessing: What do biopharma companies need?
Priyabrata Pattnaik, CEO, Ami Polymer highlights the balance between standardisation and customisation in single - use systems in biopharma manufacturing
5 mins
May 2026
Express Pharma
Ensuring Pharma compliance with testo data measurement technology
Due to the crucial necessity and its direct impact on human health and welfare, Pharma is probably the most important and critical sector among others.
3 mins
May 2026
Express Pharma
China+1 moment for pharma: How India can convert opportunity into long-term contracts
Manish Jain, Director, Naprod Life Sciences explains how India must move beyond cost advantage to lead with reliability, quality, and transparency to reshape global pharma supply chains and position itself as a trusted, long-term partner
3 mins
May 2026
Express Pharma
Beyond scale: Rethinking new frontiers in building excellence
At the Injectable Innovations Conclave 2026, hosted by Express Pharma, industry leaders examined the trends, technologies and strategies shaping the next phase of injectable growth, reports
10 mins
May 2026
Express Pharma
Waters receives CE mark for BD BACTEC FXI Culture System under EU IVDR
Next-generation blood culture system records ~3-hour faster detection time and introduces automated blood volume measurement
2 mins
May 2026
Express Pharma
JNPC: Carrying forward a 20-year old legacy
Billed as India's first bulk drug, chemicals and allied manufacturing parks and one of the most successful public-private partnerships (PPP) in the pharma sector, the Jawaharlal Nehru Pharma City (JNPC), also known as Visakha Pharma City, was set up in February 2005 as a PPP initiative by the Govt of Andhra Pradesh (GoAP) through its nodal agency Andhra Pradesh Industrial Infrastructure Corporation (APIIC) with the Ramky Group on a Build-Own-Operate (BOO) basis for 20 years.
3 mins
May 2026
Express Pharma
Romaco's sustainable blister packaging line at interpack
At this year's interpack, the Romaco Group will present its sustainable Unity 600 high-speed blister packaging line, featuring – for the first time – the PF 75 stretch bander.
6 mins
May 2026
Express Pharma
Even drug-resistant cancer targets can be tackled with the right design strategy
Dr Bajarang Kumbhar, Assistant Professor, Sunandan Divatia School of Science, NMIMS Mumbai, explains how Al-driven computational biology is reshaping CAR-T therapy and highlights how these approaches help cut drug discovery timelines and improve targeted, personalised cancer treatment, in an interaction with Kalyani Sharma
7 mins
May 2026
Express Pharma
Navigating legal and regulatory landscape of GLP-1 drugs in India
GLP-1 drugs are drawing sharp regulatory and legal scrutiny, especially with generics entering post-patent expiry. They emphasise that navigating IP, compliance, and marketing rules is now critical for stakeholders
5 mins
May 2026
Express Pharma
From back office to brain trust: How life sciences GCCs are redefining leadership hiring in India
Sai Gandhi, Partner, Positive Moves points out that life sciences GCCs in India are moving from support roles to driving core innovation and global strategy. In turn, leadership hiring is shifting toward cross-functional, globally savvy leaders who can deliver enterprise-wide impact
4 mins
May 2026
Listen
Translate
Change font size

